Inspire Medical Systems, Inc. increased revenue guidance for the fiscal year 2023. For the period, the company expects revenue guidance to between $600 million to $610 million, which would represent growth of 47% to 50% over full year 2022 revenue of $407.9 million. This compares to the prior revenue guidance of $580 million to $590 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
158.8 USD | +2.86% | +0.04% | -21.94% |
05-15 | Transcript : Inspire Medical Systems, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 04:20 PM | |
05-08 | Top Premarket Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.94% | 4.72B | |
+13.73% | 130B | |
-9.02% | 10.99B | |
+41.80% | 5.67B | |
+7.81% | 3.42B | |
-10.26% | 2.76B | |
-10.29% | 2.11B | |
-13.58% | 1.92B | |
-27.77% | 1.68B | |
-10.24% | 1.15B |
- Stock Market
- Equities
- INSP Stock
- News Inspire Medical Systems, Inc.
- Inspire Medical Systems, Inc. Increases Revenue Guidance for the Fiscal Year 2023